Australia markets closed

Ultimovacs ASA (7UM.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.5670-0.0400 (-6.59%)
At close: 03:20PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-177,880
-189,239
-167,792
-164,722
-120,552
Depreciation & amortisation
2,784
2,768
2,648
2,703
2,720
Stock-based compensation
13,184
14,256
20,395
11,595
6,777
Change in working capital
-21,714
8,885
-6,988
23,860
6,395
Other working capital
-199,426
-189,852
-167,890
-125,913
-113,505
Other non-cash items
-13,680
-13,747
-8,782
-2,883
-4,309
Net cash provided by operating activities
-199,409
-189,827
-167,695
-125,828
-108,223
Cash flows from investing activities
Investments in property, plant and equipment
-17
-25
-195
-85
-5,282
Other investing activities
-
-
-1
-
1
Net cash used for investing activities
13,928
14,034
8,691
2,977
-736
Net change in cash
-187,347
-177,640
-155,426
137,106
42,058
Cash at beginning of period
405,528
425,309
574,168
440,925
399,607
Cash at end of period
218,181
266,559
425,309
574,168
440,925
Free cash flow
Operating cash flow
-199,409
-189,827
-167,695
-125,828
-108,223
Capital expenditure
-17
-25
-195
-85
-5,282
Free cash flow
-199,426
-189,852
-167,890
-125,913
-113,505